These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26866492)

  • 21. Botulinum toxin B in the treatment of craniofacial hyperhidrosis.
    Karlqvist M; Rosell K; Rystedt A; Hymnelius K; Swartling C
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1313-7. PubMed ID: 24118460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
    Kreyden OP; Scheidegger EP
    Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective treatment of frontal hyperhidrosis with botulinum toxin A.
    Kinkelin I; Hund M; Naumann M; Hamm H
    Br J Dermatol; 2000 Oct; 143(4):824-7. PubMed ID: 11069464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of onabotulinumtoxinA and rimabotulinumtoxinB for the treatment of axillary hyperhidrosis.
    An JS; Hyun Won C; Si Han J; Park HS; Seo KK
    Dermatol Surg; 2015 Aug; 41(8):960-7. PubMed ID: 26218729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hyperhidrosis and drooling with botulinum exotoxin.
    Odderson IR
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):837-54. PubMed ID: 14580041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
    Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.
    Dressler D
    J Neurol; 2013 Mar; 260(3):701-13. PubMed ID: 22878428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Neuromodulators for Salivary, Eccrine, and Apocrine Gland Disorders.
    Rajanala S; Salame N; Dover JS
    Dermatol Surg; 2024 Sep; 50(9S):S103-S111. PubMed ID: 39196843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.
    Dressler D; Benecke R
    Eur Neurol; 2003; 49(1):34-8. PubMed ID: 12464716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Anticholinergics in the Management of Focal Hyperhidrosis in Adults and Children. A Narrative Review.
    Morgado-Carrasco D; de Lucas R
    Actas Dermosifiliogr; 2024 Apr; 115(4):356-367. PubMed ID: 37714301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical differences between botulinum neurotoxin type A and B.
    Bentivoglio AR; Del Grande A; Petracca M; Ialongo T; Ricciardi L
    Toxicon; 2015 Dec; 107(Pt A):77-84. PubMed ID: 26260691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy.
    Cohen JL; Cohen G; Solish N; Murray CA
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):17-30, v-vi. PubMed ID: 17317552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin treatment for a compensatory hyperhidrosis subsequent to an upper thoracic sympathectomy.
    Huh CH; Han KH; Seo KI; Eun HC
    J Dermatolog Treat; 2002 Jun; 13(2):91-3. PubMed ID: 12060509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary hyperhidrosis: Implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin.
    Shayesteh A; Boman J; Janlert U; Brulin C; Nylander E
    J Dermatol; 2016 Aug; 43(8):928-33. PubMed ID: 26875781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for effectiveness of botulinum toxin for hyperhidrosis.
    Bhidayasiri R; Truong DD
    J Neural Transm (Vienna); 2008; 115(4):641-5. PubMed ID: 17885725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of sialorrhea with botulinum toxin: an overview].
    Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
    Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
    Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axillary hyperhidrosis: a focused review.
    Sammons JE; Khachemoune A
    J Dermatolog Treat; 2017 Nov; 28(7):582-590. PubMed ID: 28318360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sialorrhea in Parkinson's Disease.
    Isaacson J; Patel S; Torres-Yaghi Y; Pagán F
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33142833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based medicine: botulinum toxin in focal hyperhidrosis.
    Naumann M
    J Neurol; 2001 Apr; 248 Suppl 1():31-3. PubMed ID: 11357238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.